ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 25

$481K Total Retail Price of All Prescriptions

Rank: 4 out of 25

962 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 962 patients filled at least one prescription for a schedule two drug, compared to an average of 29%.

Schedule Three
Controlled Substances

54% of this provider’s 962 patients filled at least one prescription for a schedule three drug, compared to an average of 43%.

Risky Drugs to Seniors

6% of this provider’s 5,043 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 2,573 1,620 S3 1 1
GABAPENTIN 1,015 615 2 2
OXYCODONE HCL-ACETAMINOPHEN 549 222 S2 3 3
FENTANYL 504 280 S2 4 6
TRAMADOL HCL 435 343 5 4
TIZANIDINE HCL 382 114 6 5
ZOLPIDEM TARTRATE 345 187 7 12
ENDOCET 288 183 S2 8 11
METHADONE HCL 259 140 S2 9 21
LYRICA 251 119 10 10
METHOCARBAMOL 212 99 R 11 20
CYCLOBENZAPRINE HCL 180 102 R 12 9
OXYCONTIN 154 72 S2 13 15
MORPHINE SULFATE ER 144 74 S2 14 7
OXYCODONE-ACETAMINOPHEN 143 88 S2 15 17
CYMBALTA 117 64 16 14
CARISOPRODOL 116 81 R 17 18
LIDODERM 114 57 18 27
MELOXICAM 95 56 19 13
AMITRIPTYLINE HCL 89 32 R 20 16
NAPROXEN 75 24 21 31
TRAZODONE HCL 73 39 22 24
CELEBREX 72 38 23 30
VOLTAREN 66 48 24 33
TRAMADOL HCL-ACETAMINOPHEN 66 62 24 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.